Sectra’s Year-End Report 2013/2014: Strong End To The Fiscal Year – Sectra Achieves Operating Margin Target

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Regulatory News:

SECTRA (STO:SECTB):

2013/2014 fiscal year

The IT and medical technology company Sectra (http://www.sectra.com/) (STO: SECT B) increased operating profit 49.1% to SEK 128.1 million (85.9), corresponding to an operating margin of 15.0% (10.5).

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC